Next Article in Journal
Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach
Next Article in Special Issue
Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
Previous Article in Journal
SARS-CoV2 Vaccination Adverse Events Trend in Italy: A Retrospective Interpretation of the Last Year (December 2020–September 2021)
Previous Article in Special Issue
Tolerability of the BNT162b2 COVID-19 Vaccine during Pregnancy among Polish Healthcare Professionals
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 217; https://doi.org/10.3390/vaccines10020217
Action Date Notes Link
article xml file uploaded 30 January 2022 08:55 CET Original file -
article xml uploaded. 30 January 2022 08:55 CET Update https://www.mdpi.com/2076-393X/10/2/217/xml
article pdf uploaded. 30 January 2022 08:55 CET Version of Record https://www.mdpi.com/2076-393X/10/2/217/pdf
article html file updated 30 January 2022 08:57 CET Original file -
article html file updated 31 July 2022 08:08 CEST Update https://www.mdpi.com/2076-393X/10/2/217/html
Back to TopTop